肝内胆汁淤积发病机制及药物治疗新进展

被引:42
作者
韩平
田德安
机构
[1] 华中科技大学同济医学院附属同济医院消化内科
关键词
肝内胆汁淤积; 发病机制; 药物治疗;
D O I
暂无
中图分类号
R575 [肝及胆疾病];
学科分类号
100201 [内科学];
摘要
肝内胆汁淤积是临床常见的一组症候群,其病因多种多样。国内外最新指南对其诊断和治疗进行了规范化建议。然而,目前对于肝内胆汁淤积的诊治仍未取得根本性突破。本文主要介绍肝内胆汁淤积发病机制及以发病机制为靶点的药物治疗研究新进展,旨在为该疾病研究领域的科研及临床工作者提供参考。
引用
收藏
页码:584 / 588
页数:5
相关论文
共 28 条
[1]
Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis' [J].
Beuers, Ulrich ;
Gershwin, M. Eric ;
Gish, Robert G. ;
Invernizzi, Pietro ;
Jones, David E. J. ;
Lindor, Keith ;
Ma, Xiong ;
Mackay, Ian R. ;
Pares, Albert ;
Tanaka, Atsushi ;
Vierling, John M. ;
Poupon, Raoul .
GUT, 2015, 64 (11) :1671-1672
[2]
New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR; PXR and beyond.[J].Ulrich Beuers;Michael Trauner;Peter Jansen;Raoul Poupon.Journal of Hepatology.2015, 1
[3]
Advances in pharmacotherapy for primary biliary cirrhosis [J].
Mousa, Hani S. ;
Lleo, Ana ;
Invernizzi, Pietro ;
Bowlus, Christopher L. ;
Gershwin, Merril Eric .
EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (05) :633-643
[4]
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid [J].
Hirschfield, Gideon M. ;
Mason, Andrew ;
Luketic, Velimir ;
Lindor, Keith ;
Gordon, Stuart C. ;
Mayo, Marlyn ;
Kowdley, Kris V. ;
Vincent, Catherine ;
Bodhenheimer, Henry C., Jr. ;
Pares, Albert ;
Trauner, Michael ;
Marschall, Hanns-Ulrich ;
Adorini, Luciano ;
Sciacca, Cathi ;
Beecher-Jones, Tessa ;
Castelloe, Erin ;
Boehm, Olaf ;
Shapiro, David .
GASTROENTEROLOGY, 2015, 148 (04) :751-U347
[5]
Combination therapy of bezafibrate and ursodeoxycholic acid for primary biliary cirrhosis: A meta-analysis [J].
Zhang, Yan ;
Chen, Kan ;
Dai, Weiqi ;
Xia, Yujing ;
Wang, Fan ;
Shen, Miao ;
Cheng, Ping ;
Wang, Chengfen ;
Yang, Jing ;
Zhu, Rong ;
Zhang, Huawei ;
Li, Jingjing ;
Zheng, Yuanyuan ;
Wang, Junshan ;
Lu, Jie ;
Zhou, Yingqun ;
Guo, Chuanyong .
HEPATOLOGY RESEARCH, 2015, 45 (01) :48-58
[6]
Expression of micro-RNAs in peripheral blood mononuclear cells from primary biliary cirrhosis patients [J].
Katsushima, Fumiko ;
Takahashi, Atsushi ;
Sakamoto, Natsumi ;
Kanno, Yukiko ;
Abe, Kazumichi ;
Ohira, Hiromasa .
HEPATOLOGY RESEARCH, 2014, 44 (10) :E189-E197
[7]
Chronic cholestatic liver diseases: Clues from histopathology for pathogenesis.[J].Marion J. Pollheimer;Peter Fickert;Bruno Stieger.Molecular Aspects of Medicine.2014,
[8]
MicroRNAs and cholestatic liver diseases [J].
Marin, Jose J. G. ;
Bujanda, Luis ;
Banales, Jesus M. .
CURRENT OPINION IN GASTROENTEROLOGY, 2014, 30 (03) :303-309
[9]
Bezafibrate normalizes alkaline phosphatase in primary biliary cirrhosis patients with incomplete response to ursodeoxycholic acid [J].
Lens, Sabela ;
Leoz, Maria ;
Nazal, Leyla ;
Bruguera, Miguel ;
Pares, Albert .
LIVER INTERNATIONAL, 2014, 34 (02) :197-203
[10]
The Receptor TGR5 Protects the Liver From Bile Acid Overload During Liver Regeneration in Mice [J].
Pean, Noemie ;
Doignon, Isabelle ;
Garcin, Isabelle ;
Besnard, Aurore ;
Julien, Boris ;
Liu, Bingkai ;
Branchereau, Sophie ;
Spraul, Anne ;
Guettier, Catherine ;
Humbert, Lydie ;
Schoonjans, Kristina ;
Rainteau, Dominique ;
Tordjmann, Thierry .
HEPATOLOGY, 2013, 58 (04) :1451-1460